{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T07:19:00Z","timestamp":1778656740869,"version":"3.51.4"},"reference-count":40,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.neo.2014.08.010","type":"journal-article","created":{"date-parts":[[2014,11,20]],"date-time":"2014-11-20T18:03:20Z","timestamp":1416506600000},"page":"909-917","source":"Crossref","is-referenced-by-count":16,"title":["Neurogenin 3\u2013Directed Cre Deletion of Tsc1 Gene Causes Pancreatic Acinar Carcinoma"],"prefix":"10.1016","volume":"16","author":[{"given":"Li","family":"Ding","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingling","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weizhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.neo.2014.08.010_bb0005","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","article-title":"Global cancer statistics, 2002","volume":"55","author":"Parkin","year":"2005","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.neo.2014.08.010_bb0010","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3322\/canjclin.54.1.8","article-title":"Cancer statistics, 2004","volume":"54","author":"Jemal","year":"2004","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"10.1016\/j.neo.2014.08.010_bb0015","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJM199202133260706","article-title":"Pancreatic carcinoma","volume":"326","author":"Warshaw","year":"1992","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.neo.2014.08.010_bb0020","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1634\/theoncologist.2011-0231","article-title":"Acinar cell carcinoma of the pancreas: new genetic and treatment insights into a rare malignancy","volume":"16","author":"Lowery","year":"2011","journal-title":"Oncologist"},{"issue":"3","key":"10.1016\/j.neo.2014.08.010_bb0025","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0002-9440(10)64917-6","article-title":"Genetic and immunohistochemical analysis of pancreatic acinar cell carcinoma: frequent allelic loss on chromosome 11p and alterations in the APC\/beta-catenin pathway","volume":"160","author":"Abraham","year":"2002","journal-title":"Am J Pathol"},{"issue":"5897","key":"10.1016\/j.neo.2014.08.010_bb0030","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1126\/science.1164368","article-title":"Core signaling pathways in human pancreatic cancers revealed by global genomic analyses","volume":"321","author":"Jones","year":"2008","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.neo.2014.08.010_bb0035","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1053\/j.gastro.2012.03.002","article-title":"What we have learned about pancreatic cancer from mouse models","volume":"142","author":"Perez-Mancera","year":"2012","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.neo.2014.08.010_bb0040","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.surg.2005.06.028","article-title":"Expression and prognostic value of tuberous sclerosis complex 2 gene product tuberin in human pancreatic cancer","volume":"138","author":"Kataoka","year":"2005","journal-title":"Surgery"},{"issue":"4","key":"10.1016\/j.neo.2014.08.010_bb0045","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1081\/CNV-200027144","article-title":"The tuberous sclerosis complex genes in tumor development","volume":"22","author":"Mak","year":"2004","journal-title":"Cancer Invest"},{"issue":"16","key":"10.1016\/j.neo.2014.08.010_bb0050","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1101\/gad.1212704","article-title":"Upstream and downstream of mTOR","volume":"18","author":"Hay","year":"2004","journal-title":"Genes Dev"},{"issue":"6021","key":"10.1016\/j.neo.2014.08.010_bb0055","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1126\/science.1200609","article-title":"DAXX\/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors","volume":"331","author":"Jiao","year":"2011","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.neo.2014.08.010_bb0060","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1158\/2159-8290.CD-11-0031","article-title":"PTEN is a major tumor suppressor in pancreatic ductal adenocarcinoma and regulates an NF-kappaB-cytokine network","volume":"1","author":"Ying","year":"2011","journal-title":"Cancer Discov"},{"key":"10.1016\/j.neo.2014.08.010_bb0065","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1038\/srep03230","article-title":"mTOR plays critical roles in pancreatic cancer stem cells through specific and stemness-related function","volume":"3","author":"Matsubara","year":"2013","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.neo.2014.08.010_bb0070","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1158\/0008-5472.CAN-12-2014","article-title":"Phosphorylation of ribosomal protein S6 attenuates DNA damage and tumor suppression during development of pancreatic cancer","volume":"73","author":"Khalaileh","year":"2013","journal-title":"Cancer Res"},{"issue":"9","key":"10.1016\/j.neo.2014.08.010_bb0075","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1002\/ijc.21532","article-title":"In vivo antitumor effect of the mTOR inhibitor CCI-779 and gemcitabine in xenograft models of human pancreatic cancer","volume":"118","author":"Ito","year":"2006","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.neo.2014.08.010_bb0080","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s13277-011-0290-2","article-title":"The dual PI3K\/mTOR inhibitor NVP-BGT226 induces cell cycle arrest and regulates Survivin gene expression in human pancreatic cancer cell lines","volume":"33","author":"Glienke","year":"2012","journal-title":"Tumour Biol"},{"issue":"79","key":"10.1016\/j.neo.2014.08.010_bb0085","first-page":"2129","article-title":"Rapamycin enhances the anti-tumor effect of gemcitabine in pancreatic cancer cells","volume":"54","author":"Okada","year":"2007","journal-title":"Hepatogastroenterology"},{"issue":"20","key":"10.1016\/j.neo.2014.08.010_bb0090","doi-asserted-by":"crossref","first-page":"6993","DOI":"10.1158\/1078-0432.CCR-04-0808","article-title":"Effect of rapamycin alone and in combination with antiangiogenesis therapy in an orthotopic model of human pancreatic cancer","volume":"10","author":"Stephan","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.neo.2014.08.010_bb0095","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000329386","article-title":"From targets to treatments: a review of molecular targets in pancreatic neuroendocrine tumors","volume":"94","author":"Wiedenmann","year":"2011","journal-title":"Neuroendocrinology"},{"issue":"4","key":"10.1016\/j.neo.2014.08.010_bb0100","doi-asserted-by":"crossref","first-page":"817","DOI":"10.2337\/db07-0617","article-title":"Homocysteine upregulates resistin production from adipocytes in vivo and in vitro","volume":"57","author":"Li","year":"2008","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.neo.2014.08.010_bb0105","doi-asserted-by":"crossref","DOI":"10.1210\/en.2009-0372","article-title":"Gastric mammalian target of rapamycin signaling regulates ghrelin production and food intake","volume":"150","author":"Xu","year":"2009","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/j.neo.2014.08.010_bb0110","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1002\/hep.26007","article-title":"Hepatic transforming growth factor beta gives rise to tumor-initiating cells and promotes liver cancer development","volume":"56","author":"Wu","year":"2012","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.neo.2014.08.010_bb0115","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1158\/1078-0432.CCR-06-2570","article-title":"Identification of a highly effective rapamycin schedule that markedly reduces the size, multiplicity, and phenotypic progression of tobacco carcinogen-induced murine lung tumors","volume":"13","author":"Granville","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.neo.2014.08.010_bb0120","doi-asserted-by":"crossref","first-page":"R46","DOI":"10.1186\/bcr1533","article-title":"The mTOR inhibitor rapamycin down-regulates the expression of the ubiquitin ligase subunit Skp2 in breast cancer cells","volume":"8","author":"Shapira","year":"2006","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.neo.2014.08.010_bb0125","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/978-1-62703-287-2_13","article-title":"Quantification of murine pancreatic tumors by high-resolution ultrasound","volume":"980","author":"Sastra","year":"2013","journal-title":"Methods Mol Biol"},{"issue":"4","key":"10.1016\/j.neo.2014.08.010_bb0130","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1159\/000055835","article-title":"TGF alpha transgenic mice. A model of pancreatic cancer development","volume":"1","author":"Greten","year":"2001","journal-title":"Pancreatology"},{"issue":"9","key":"10.1016\/j.neo.2014.08.010_bb0135","first-page":"2016","article-title":"Preinvasive pancreatic neoplasia of ductal phenotype induced by acinar cell targeting of mutant Kras in transgenic mice","volume":"63","author":"Grippo","year":"2003","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.neo.2014.08.010_bb0140","first-page":"696","article-title":"Pancreatic carcinomas of acinar and mixed acinar\/ductal phenotypes in Ela-1-myc transgenic mice do not contain c-K-ras mutations","volume":"145","author":"Schaeffer","year":"1994","journal-title":"Am J Pathol"},{"issue":"6747","key":"10.1016\/j.neo.2014.08.010_bb0145","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/23716","article-title":"Notch signalling controls pancreatic cell differentiation","volume":"400","author":"Apelqvist","year":"1999","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.neo.2014.08.010_bb0150","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2337\/diabetes.49.2.163","article-title":"Independent development of pancreatic alpha- and beta-cells from neurogenin3-expressing precursors: a role for the notch pathway in repression of premature differentiation","volume":"49","author":"Jensen","year":"2000","journal-title":"Diabetes"},{"issue":"10","key":"10.1016\/j.neo.2014.08.010_bb0155","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1242\/dev.129.10.2447","article-title":"Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors","volume":"129","author":"Gu","year":"2002","journal-title":"Development"},{"issue":"4","key":"10.1016\/j.neo.2014.08.010_bb0160","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1073\/pnas.97.4.1607","article-title":"neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas","volume":"97","author":"Gradwohl","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.neo.2014.08.010_bb0165","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ydbio.2004.03.013","article-title":"Neurogenin 3-expressing progenitor cells in the gastrointestinal tract differentiate into both endocrine and non-endocrine cell types","volume":"270","author":"Schonhoff","year":"2004","journal-title":"Dev Biol"},{"issue":"1","key":"10.1016\/j.neo.2014.08.010_bb0170","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ydbio.2009.12.009","article-title":"Neurog3 gene dosage regulates allocation of endocrine and exocrine cell fates in the developing mouse pancreas","volume":"339","author":"Wang","year":"2010","journal-title":"Dev Biol"},{"issue":"2","key":"10.1016\/j.neo.2014.08.010_bb0175","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ydbio.2011.10.025","article-title":"Competence of failed endocrine progenitors to give rise to acinar but not ductal cells is restricted to early pancreas development","volume":"361","author":"Beucher","year":"2012","journal-title":"Dev Biol"},{"issue":"1","key":"10.1016\/j.neo.2014.08.010_bb0180","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/2050-7771-1-6","article-title":"Imaging heterogeneity in the mitochondrial redox state of premalignant pancreas in the pancreas-specific PTEN-null transgenic mouse model","volume":"1","author":"Xu","year":"2013","journal-title":"Biomarker Res"},{"issue":"217","key":"10.1016\/j.neo.2014.08.010_bb0185","doi-asserted-by":"crossref","first-page":"ra24","DOI":"10.1126\/scisignal.2002739","article-title":"Chronic activation of mTOR complex 1 is sufficient to cause hepatocellular carcinoma in mice","volume":"5","author":"Menon","year":"2012","journal-title":"Sci Signal"},{"issue":"9","key":"10.1016\/j.neo.2014.08.010_bb0190","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1038\/modpathol.2011.83","article-title":"Analysis of LKB1 mutations and other molecular alterations in pancreatic acinar cell carcinoma","volume":"24","author":"de Wilde","year":"2011","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1016\/j.neo.2014.08.010_bb0195","doi-asserted-by":"crossref","first-page":"e150","DOI":"10.1200\/JCO.2010.32.7825","article-title":"mTOR inhibitor treatment of pancreatic cancer in a patient With Peutz-Jeghers syndrome","volume":"29","author":"Klumpen","year":"2011","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.neo.2014.08.010_bb0200","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/path.4310","article-title":"Whole-exome sequencing of pancreatic neoplasms with acinar differentiation","volume":"232","author":"Jiao","year":"2014","journal-title":"J Pathol"}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147655861400116X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147655861400116X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T23:44:51Z","timestamp":1650671091000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147655861400116X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S147655861400116X"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2014.08.010","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]}}}